David R. Bauer
Lawyers
Filters
UCT acquisition of HIS Innovations Group
We advised UCT on the acquisition
Roche $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant
We are advising Roche on the acquisition
Inventiva $58 million at-the-market offering
The American depositary shares are listed on Nasdaq
HilleVax $115 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
RayzeBio $358 million IPO
The stock is listed on the Nasdaq Global Market
Advanced Energy Industries $575 million convertible senior note offering
The 2.5% convertible senior notes are due 2028
CSG Systems International $425 million convertible senior notes offering
The 3.875% convertible notes are due 2028
Tetra Tech $575 million convertible notes offering and capped call transactions
The 2.25% convertible senior notes are due 2028
AN2 Therapeutics $70 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Shockwave Medical $750 million convertible senior notes offering
The 1% convertible notes are due 2028